Purchase Order 75N95024P00482
Award Date 9/30/24
Potential Completion Date 4/29/25
Potential Value $64K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sweden
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The U.S. National Institute on Aging, a civilian federal agency, awarded a $21,787.50 firm fixed-price purchase order contract to Scantox Neuro GMBH, a for-profit organization, to provide reagent materials including hydroxychloroquine sulfate and related chiral separation/purification products. The contract has a period of performance through January 22, 2025 and was awarded on December 23, 2024 with no set-aside designation.</p>
- The National Institute on Aging awarded a $249,000 firm fixed-price purchase order to Scantox Neuro GMBH, an Austria-based pharmaceutical research firm specializing in neurological and Alzheimer's disease studies. The contract, awarded on September 30, 2022, with an ultimate completion date of May 2, 2025, supports tolerability studies of candidate Alzheimer's disease drugs and efficacy testing of poly(L-lysine succinylated)-hydroxychloroquine (PLS-HCQ) in a transgenic Alzheimer's mouse model....
- This is a firm fixed-price delivery order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract, valued at $858,106.08, is for the experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. This work supports ongoing NIA research initiatives such as the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and PREVENT-AD studies....
- This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...
- This is a $24,739 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to the non-profit organization Hjartavernd SES in Iceland. The contract is for assaying services to investigate biologic changes in the transition from normal to Alzheimer's dementia cognitive states using an omics approach. Hjartavernd SES has previously provided statistical analysis, DNA sample processing, protein biomarker research, and other scientific services to...
- This is a $199,812 firm fixed price purchase order awarded by the National Institutes of Health's (NIH) National Institute on Aging (NIA) to QPS Austria GMBH, a contract research organization. The contract is for in vivo efficacy studies of a candidate Alzheimer's treatment in a transgenic mouse model. This award is part of the NIA's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which aims to identify FDA-approved drugs that may be repurposed as disease-modifying...
- This is a $33,979.92 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to The Johns Hopkins University. The contract is for the "Characterization of Human Arterial Immunoglobulin Repertoire (CHAIR)" project, with a period of performance from September 1, 2020 to August 31, 2021, with an optional 12-month extension. The contract was awarded based on a Sources Sought notice published in June 2020, which sought information on the...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $43,358 firm fixed price purchase order contract to The Johns Hopkins University to provide statistical support, including consulting, programming, and generating publication-quality materials, to assist the Laboratory of Behavioral Neuroscience in analyzing the proteomic signatures of dementia risk and related phenotypes using data from the Atherosclerosis Risk in Communities (ARIC)...
- <p>The National Institutes of Health National Institute on Aging, within the Department of Health and Human Services, awarded a $638,000 firm fixed price delivery order contract to QPS Austria GmbH. The contract is for experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. The period of performance is from June 1, 2022 through May 31, 2023, with all work to be conducted in Austria by QPS Austria GmbH as the prime contractor.</p>
- This is a $249,334 firm fixed-price purchase order awarded by the National Institute on Aging (NIA) to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract supports pharmacodynamic and tolerability studies of candidate Alzheimer's disease (AD) drugs using a transgenic AD mouse model. This work builds on NIA's ongoing efforts under the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and Experimental Validation of Candidate Alzheimer's Disease Treatments...